Drug Profile
Research programme: antimicrobial peptides - Riptide Bioscience
Alternative Names: RP 438; RP 444Latest Information Update: 28 Sep 2020
Price :
$50
*
At a glance
- Originator Riptide Bioscience
- Class Peptide antibiotics
- Mechanism of Action Cell membrane modulators
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- No development reported Bacterial infections
Most Recent Events
- 28 Sep 2020 No recent reports of development identified for preclinical development in Bacterial-infections in USA (Topical)
- 28 Sep 2020 No recent reports of development identified for research development in Bacterial-infections in USA (Parenteral)
- 07 Aug 2016 Early research in Bacterial infections in USA (Parenteral)